rates and erectile dysfunction. In this study, we investigated the feasibility of engineering corporal constructs using cavernosal smooth muscle (SMCs) and endothelial cells (ECs) seeded onto 3D acellular corporal collagen matrices.
INTRODUCTION AND OBJECTIVES:
Men with Peyronie's Disease (PD) may experience penile shaft narrowing and instability. Little literature exists on penile girth changes and their impact on sexual function and bother. The aim of this study was to assess girth discrepancy and its association with penile instability and bother.
METHODS: PD patients have girth measurements and instability grading during their duplex Doppler ultrasound. All patients completed three validated instruments: the PD questionnaire (PDQ), Self-Esteem and Relationship (SEAR) questionnaire and a depression questionnaire (CES-D). Comorbidities, demographic data and PD characteristics were recorded. We limited this analysis to men with mid-shaft curvature. Clinically meaningful bother was defined as !9 on the PDQ bother subscale. Two categories for significant girth differences were (i) comparing !1cm vs <1cm; (ii) !10% vs <10%. Unadjusted and adjusted effects of girth discrepancy, instability and PD duration were assessed on the outcome of clinically significant bother (as defined by ! 9 on PDQ bother subscale) using logistic regression models.
RESULTS: 175 men had complete girth data. Mean age was 57.5 AE 10 years. Midshaft curvature was the most common (67%) and was the focus of this study. Mean girth difference between base and point of maximum curvature (PMC) was 0.7 AE 0.5 cm and mean girth difference change at PMC was 6 AE 4%. There was no change in the rate of instability in men with a girth difference of ! 1cm (57 vs 45%; p[0.124) or in men with a ! 10% change in girth (42 vs 58%; p[0.195). There was no statistically significant difference in CES-D or SEAR scores or overall PDQ bother domain score in men with significant girth differences. However, Q11 on the PDQ, (bother associated with appearance of erect penis), was rated higher in men with ! 1cm girth difference (2.4 AE 0.9 vs. 1.9 AE 1.2; p[0.043) and ! 10% girth difference (2.69 AE 0.9 vs. 1.9 AE 1.2, p[0.038). On multivariate analysis, the degree of primary curvature was predictive of clinically significant bother (p[0.0048) as was the total SEAR score (p[<0.001).
CONCLUSIONS: We describe the prevalence and magnitude of girth differences in men with PD. Girth discrepancy was not associated with worsening instability or the bother domain score on the PDQ. Clinically significant bother was associated with the degree of primary curvature and total SEAR score on MVA.
Source of Funding: None

MP65-03 LONG-TERM PATIENT REPORTED OUTCOMES IN MEN WITH PEYRONIE'S DISEASE WHO UNDERGO CONSERVATIVE MANAGEMENT
Edward Capoccia*, Matthew Ziegelmann, Jacob Emerson, Claudia Ofori-Marfoh, Joseph Lankford, Laurence Levine, Chicago, IL INTRODUCTION AND OBJECTIVES: We sought to evaluate patient-reported outcomes in men with PD who elect conservative management without surgery or intralesional collagenase Clostridium histolyticum (CCH).
METHODS: We identified all patients with PD evaluated at our institution by a single provider between May 2012 and January 2018 who elected non-surgical and non-CCH management. A PD-specific questionnaire was sent via email software to all who met inclusion criteria. The questionnaire included assessments of changes in penile deformity, sexual function, and psychological aspects of PD from the time of initial diagnosis to present.
RESULTS: A total of 101/514 (19.7%) patients responded to our email questionnaire. The median age was 55 (IQR 48;60) and median PD duration prior to survey completion was 45 months (IQR 28.5;64). Prior treatments included penile traction (PT; 55%), oral therapy (37%), intralesional injections other than CCH (8%), and 29% reported no prior treatment. 49% of patients reported at least some improvement in their curvature including 18% with "mild improvement" (<30 degrees), 23% with "significant improvement" (>30 degrees), and 8% with resolution. 84% of patients reported penile length loss at baseline, with > 30% reporting further shortening. Moreover, 63% reported that PD negatively impacted their self-esteem and 68% reported that PD negatively impacted their partners' well-being. Men ranked length loss as the most bothersome aspect of PD. In subgroup analysis, men reporting at least a mild improvement in their curvature were more likely to also have improvement in their length loss (50% vs 24%, p[0.001) and were less likely to have a negative impact on current or prior sexual relationships (51% vs 68%, p[0.04). In those patients who did not pursue any treatment, penile curvature improvement rates were lower (24% vs 49%; p[0.017). Men who underwent PT more likely to report improvement in their curvature (64% vs 27%, p[0.0005) and length loss (35% vs 10%, p[0.0075) .
CONCLUSIONS: Our survey provides important data on patient-reported outcomes in men electing non-surgical and non-CCH interventions. Although 49% of men noted at least a mild improvement in their curvature over time, a majority had declining erectile function, decreased intercourse satisfaction, and psychosocial distress. Men who elected treatment with oral, PT, and non-CCH intralesional injections were more likely to report subjective improvement in curvature and penile length. These data are useful when counseling men with PD.
